Ethema Health CORP 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
Ethema Health Corporation reported a net income of $66,136 for Q3 2025, driven by significant revenue growth from recent acquisitions, despite ongoing liquidity challenges and a substantial accumulated deficit.
OTC.Pink
Ethema Health Corporation reported significant revenue growth in Q2 2025 driven by acquisitions, but continues to face substantial doubt about its ability to continue as a going concern due to ongoing losses and a working capital deficiency.
OTC.Pink
Ethema Health Corporation reported a significant increase in net loss and a substantial working capital deficiency for Q1 2025, despite revenue growth driven by recent acquisitions.
OTC.Pink
Ethema Health Corporation's Q3 2024 results show a 30% increase in revenue compared to the same period last year, but also a significant increase in operating expenses leading to an operating loss.
OTC.Pink
Ethema Health Corporation's Q2 2024 results show a net loss and increased operating expenses, raising concerns about the company's ability to continue as a going concern.
OTC.Pink
Ethema Health Corporation's Q1 2024 results show a widened operating loss due to increased expenses, despite consistent revenue compared to the same period last year.